Dendritic cell targeted HIV‐1 gag protein vaccine provides help to a recombinant Newcastle disease virus vectored vaccine including mobilization of protective CD8⁺ T cells

By  

Immunity, Inflammation And Disease, Vol. 6, Iss. 1, 2018-03 ,pp. : 163-175

John Wiley & Sons Inc

Access to resources Recommend Favorite

Progress in development and testing of novel recombinant vaccine platforms for HIV

By Weiner David  

Springer Seminars in Immunopathology, Vol. 28, Iss. 3, 2006-11 ,pp. : 195-196

Springer Publishing Company

Access to resources Recommend Favorite

Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector

By Clarke David   Cooper David   Egan Michael   Hendry R.   Parks Christopher   Udem Stephen  

Springer Seminars in Immunopathology, Vol. 28, Iss. 3, 2006-11 ,pp. : 239-253

Springer Publishing Company

Access to resources Recommend Favorite

Vaccine development against HIV-1: Current perspectives and future directions

By Edgeworth Rebecca   Juan Homero   Rosenzweig Jason   Nguyen Nang   Boyer Jean   Ugen Kenneth  

Immunologic Research, Vol. 25, Iss. 1, 2002-02 ,pp. : 53-74

Humana Press, Inc

Access to resources Recommend Favorite

A novel tumor-vaccine cell therapy using bone marrow-derived dendritic cell type 1 and antigen-specific T h 1 cells

By Sato M.   Chamoto K.   Nishimura T.  

International Immunology, Vol. 15, Iss. 7, 2003-07 ,pp. : 837-843

Oxford University Press

Access to resources Recommend Favorite